tiprankstipranks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Stock Investors

Compare
319 Followers
Based on 788,174 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MLTX
On average, investors allocate 2.92% of their portfolios to MLTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 788,174 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MLTX

0.4%
Last 7
Days
0.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MLTX, out of 788,174 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MLTX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.01%
$51.78
Based on the activity of investors who made their portfolios public
The table shows changes in MLTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MLTX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.90%
-0.95%
+1.82%
3.52B
Healthcare
Spotify Technology SA
5.19%
+1.37%
+7.23%
127.85B
Communication Services
DraftKings
5.07%
-1.00%
-1.47%
43.65B
Consumer Cyclical
Riot Platforms
4.81%
-1.98%
-0.62%
3.99B
Financial
Celestica
5.70%
+0.25%
+11.76%
14.48B
Technology
Fortinet
3.70%
+1.12%
+8.24%
87.54B
Technology
Intuit
2.88%
-1.16%
-5.27%
162.09B
Technology
BigBearai Holdings
4.84%
+2.04%
+33.95%
1.89B
Technology
Devon Energy
4.15%
+2.89%
+1.44%
25.02B
Energy
Trade Desk
3.54%
+2.94%
+13.56%
37.38B
Technology
Based on the activity of 788,174 active portfolios
Open your Smart Portfolio

MLTX Investor Analysis

MLTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.6%
of MLTX holders
are under 35
Average Segment Performance
Average P/E Ratio39.08
Beta11.18
Dividend Yield3.84%
MLTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.6%
of MLTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio37.72
Beta20.89
Dividend Yield3.28%
MLTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
43.8%
of MLTX holders
are over 55
Average Segment Performance
Average P/E Ratio36.08
Beta10.18
Dividend Yield3.48%
Overview of age group and performance of MLTX stock investors
See who invests in MLTX according to age group and performance.

FAQ

How many retail Investors hold MLTX?
<0.1% of TipRanks' retail investors hold MLTX in their portfolios.
    What is MLTX Investor Sentiment?
    MLTX’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of MLTX in the last 7 days?
      ▼ 0.4% of TipRanks' retail investors changed their holding of MLTX in the last 7 days.
        What percentage of retail investors changed their holding of MLTX in the last 30 days?
        ▼ 0.5% of TipRanks' retail investors changed their holding of MLTX in the last 30 days.
          What is the average age of retail investors who hold MLTX?
          The average age of MLTX Holders is over 55.
            What other stocks have MLTX investors also bought?
            MLTX Investors also bought VKTX, SPOT, DKNG, RIOT, CLS, FTNT, INTU, BBAI, DVN, TTD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              BDXBecton Dickinson
              CNCCentene
              CHRSCoherus Biosciences
              CICigna
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis